Application of an indoleamine 2,3-dioxygenase-expressing skin substitute improves scar formation in a fibrotic animal model.
Claudia
C
Chavez-Munoz
Ryan
R
Hartwell
Reza B
RB
Jalili
Matthew
M
Carr
Ruhangiz T
RT
Kilani
Seyed Mehdi
SM
Jafarnejad
Elham
E
Rahmani-Neishabour
Farshad
F
Forouzandeh
Steven T
ST
Boyce
Aziz
A
Ghahary
D000818:Animals; D002921:Cicatrix / Q000378:metabolism / Q000473:pathology*; D024042:Collagen Type I / Q000235:genetics / Q000378:metabolism; D000090602:Collagen Type I, alpha 1 Chain; D005347:Fibroblasts; D015870:Gene Expression; D006085:Graft Survival; D007155:Immunologic Factors / Q000235:genetics / Q000378:metabolism*; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000235:genetics / Q000378:metabolism*; D020781:Matrix Metalloproteinase 1 / Q000235:genetics / Q000378:metabolism; D011817:Rabbits; D012867:Skin / Q000378:metabolism* / Q000473:pathology; D017768:Skin, Artificial; D014161:Transduction, Genetic; D014945:Wound Healing
D024042:Collagen Type I; D000090602:Collagen Type I, alpha 1 Chain; D007155:Immunologic Factors; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D020781:Matrix Metalloproteinase 1